Human CD19+ B cells isolated from peripheral blood using positive immunomagnetic selection, cryopreserved, ≥10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Human CD19+ B cells isolated from peripheral blood using positive immunomagnetic selection, cryopreserved, ≥10 million cells
Human CD19+ B cells isolated from peripheral blood using negative immunomagnetic selection, cryopreserved, ≥10 million cells
Do you need a modified version of this cell product, such as different vialing sizes, matched immune cell isolations or isolations from special donors or species? Contact Lonza CellBio Services to discuss custom isolation, expansion, and testing options for your research
Human CD19+ B cells isolated from peripheral blood using negative immunomagnetic selection, cryopreserved, ≥10 million cells
Cryopreserved ampule of Human Mesenchymal Stem Cells (hMSCs) containing ≥750,000 cells
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 50 million cells with population frequency information
Cryopreserved ampule of Human Peripheral Blood Mononuclear Cells (hPBMC) containing ≥ 100 million cells with cell type frequency information
Cryopreserved ampule of Human Dental Pulp Stem Cells containing ≥1 million cells
-
Instructions - Poietics™ Immune Cell SystemsInstructions For Proper Use
-
TechSheet - Poietics™ Human Adipose Derived Stem Cells (ADSC)
-
TechSheet - Human Dental Pulp Stem Cell SystemsTechnical Use and Product Information
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
-
Transfection Protocol for Human B Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human B cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
Primary Blood and Immune Cells for ResearchPresentation (PDF) showcasing Lonza's portfolio and capabilities of primary blood and immune cells for research.
-
Cold Storage of Fresh Leukopak Maintains Cell Viability and FunctionalityLearn how advanced cold storage approaches enable optimal levels of product integrity, quality, stability and viability
-
Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell GenerationPoster on inducible Cas9 T Cells
-
Primary Cells and Media Reference GuideA comprehensive collection of Lonza primary cell and media products supporting many research areas.
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.